Sort   by:  
 Page size 
UnknownNTRK2 Fusion driven pediatric glioblastoma: Identification of oncogenic Drivers via integrative Genome and transcriptome profiling.
Not available
S-EPMC7981675 | biostudies-literature
UnknownWaning Vaccine Immunity and Vaccination Responses in Children Treated for Acute Lymphoblastic Leukemia: A Canadian Immunization Research Network Study.
Not available
S-EPMC7713683 | biostudies-literature
UnknownOutcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial.
Not available
S-EPMC4119804 | biostudies-literature
UnknownTubular Injury Biomarkers to Predict CKD and Hypertension at 3 Months Post-Cisplatin in Children.
Not available
S-EPMC11219117 | biostudies-literature
UnknownPharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes.
Not available
S-EPMC6519044 | biostudies-literature
UnknownComparative Tumor RNA Sequencing Analysis for Difficult-to-Treat Pediatric and Young Adult Patients With Cancer.
Not available
S-EPMC6822083 | biostudies-literature
UnknownReplication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children.
Not available
S-EPMC4006820 | biostudies-literature
UnknownA coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.
Not available
S-EPMC4552570 | biostudies-literature
UnknownHigher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent.
Not available
S-EPMC4684079 | biostudies-literature
UnknownTCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study.
Not available
S-EPMC8280110 | biostudies-literature
Sort   by:  
 Page size